All News

Radiotherapy is one of the treatment modalities in the management of patients with cancer. It is highly effective in women with early stages of malignancy but it results in the loss of ovarian function.

Researchers at University Hospital CASE Medical Center (UHCMC) in Cleveland, Ohio have embarked on new clinical studies that explore early detection of endometrial and cervical cancers in women. Results of these breakthrough studies could save countless lives and extend the average life expectancy in women.

The American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for management of ASC-H is colposcopic examination followed by biopsy. HPV testing (HPVT) is recommended after a negative biopsy result.

Research on quality and satisfaction with care during palliative chemotherapy in oncology patients has been limited. The objective was to assess the association between patient's satisfaction with care and symptom severity and to evaluate test-retest of a satisfaction survey in this study population.

The Early-7 (E7) protein of HPV binds to the underphosphorelated form of the tumor suppressor protein - pRb and displaces the E2F transcription factor that is normally bound by pRb. The latent membrane protein-1 (LMP-1) of EBV prevents apoptosis of B cells by up regulating the expression of bcl-2, and it activates growth promoting pathway that are normally triggered by T cell - derivate signal.

WT1 is a tumor suppressor gene responsible for Wilms' tumor. WT1 reactivity is limited to ovarian serous carcinomas. Recent studies have shown that WT1 plays an important role in the progression of disease and indicates a poorer prognosis of human malignancies such as acute myeloid leukemia and breast cancer.

Fallopian tube prolapse as a complication of abdominal hysterectomy is a rare occurrence. A case with fallopian tube prolapse was managed by a combined vaginal and laparoscopic approach and description of the operative technique is presented.

Cervical cancer remains one of the greatest killers of women worldwide. It is difficult to foresee a dramatic increase in cure rate even with the most optimal combination of cytotoxic drugs, surgery, and radiation; therefore, testing of molecular targeted therapies against this malignancy is highly desirable.

Human Papillomavirus has emerged as a distinct cause of cervical changes in young women. Its prevalence is continuously growing and is considered at epidemic proportions with 20 million Americans already infected and 5.5 million new cases reported annually. (2) (Center for Disease Control and Prevention, Tracking the Hidden Epidemics., Trends in STDs in the U.S. 2000, Atlanta, Georgia, 2000)

Roberta Speyer, President of OBGYN.net interviews MH Lee, PhD, CEO of Medison, on the recent acquisition of Kretztechnik Austria by GE

Roberta Speyer, President of OBGYN.net interviews Omar Ishrak, Vice President and Global Manager of GE Ultrasound on the recent acquisition of Kretztechnik Austria by GE

Roberta's Lap-Band Surgery

OBGYN.net Broadcasting present Part VIII of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting present Part VIII of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

Roberta's Lap-Band Surgery

OBGYN.net Broadcasting presents Part VII of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

At this time, three years post-op, Roberta is satisfied with the outcome of her surgery and hopes you have found her story helpful in your search for answers.

OBGYN.net Broadcasting presents Part VII of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting present Part VI of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting present Part VI of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting presents Part V of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting presents Part V of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting presents Part IV of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op.

Gastric Lap Band Surgery For Weight Loss

June 5, 2001 - FDA today approved a new surgically implanted device to help severely obese people lose weight. The product, the Lap-Band Adjustable Gastric Banding System, made by BioEnterics Corporation of Carpinteria, Calif., is an inflatable band that is placed around the upper stomach to create a small gastric pouch. This limits food consumption and creates an earlier feeling of fullness.

OBGYN.net Broadcasting presents Part IV of a series of presentations on Weight Loss Surgery. This project is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting presents Part III of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.

OBGYN.net Broadcasting presents Part III of a series on Weight Loss Surgery. This series is unique in that we follow the patient from pre-op to one year post-op.